{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619 728 4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1065650, "exercisedValue": 0, "unexercisedValue": 4803451}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 48, "title": "Co-Founder & COO", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 630800, "exercisedValue": 0, "unexercisedValue": 2216617}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 68, "title": "Chief Technology Officer", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2023, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Senior VP of Corporate Development & Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 58, "title": "Chief Development Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erik  Goluboff", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.3, "open": 9.21, "dayLow": 8.665, "dayHigh": 9.41, "regularMarketPreviousClose": 9.3, "regularMarketOpen": 9.21, "regularMarketDayLow": 8.665, "regularMarketDayHigh": 9.41, "payoutRatio": 0.0, "beta": 1.09, "forwardPE": -4.316832, "volume": 734368, "regularMarketVolume": 734368, "averageVolume": 295278, "averageVolume10days": 277770, "averageDailyVolume10Day": 277770, "bid": 8.67, "ask": 8.75, "bidSize": 1, "askSize": 1, "marketCap": 462944800, "fiftyTwoWeekLow": 8.66, "fiftyTwoWeekHigh": 29.6, "fiftyDayAverage": 12.2356, "twoHundredDayAverage": 17.3988, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 127725424, "profitMargins": 0.0, "floatShares": 21075120, "sharesOutstanding": 53090000, "sharesShort": 3915958, "sharesShortPriorMonth": 3683138, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0774, "heldPercentInsiders": 0.041739997, "heldPercentInstitutions": 0.95734, "shortRatio": 11.64, "shortPercentOfFloat": 0.144, "impliedSharesOutstanding": 53090000, "bookValue": 6.762, "priceToBook": 1.2895594, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -86481000, "trailingEps": -1.51, "forwardEps": -2.02, "enterpriseToEbitda": -1.232, "52WeekChange": -0.50454545, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 8.72, "targetHighPrice": 33.0, "targetLowPrice": 28.0, "targetMeanPrice": 30.0, "targetMedianPrice": 30.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 341440992, "totalCashPerShare": 6.431, "ebitda": -103658000, "totalDebt": 6222000, "quickRatio": 23.533, "currentRatio": 23.809, "debtToEquity": 1.813, "returnOnAssets": -0.22093001, "returnOnEquity": -0.31596002, "freeCashflow": -41145624, "operatingCashflow": -69774000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tyra Biosciences, Inc.", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -3.5156002, "fiftyDayAverageChangePercent": -0.2873255, "twoHundredDayAverageChange": -8.6788, "twoHundredDayAverageChangePercent": -0.49881598, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "regularMarketChange": -0.5799999, "regularMarketDayRange": "8.665 - 9.41", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 295278, "fiftyTwoWeekLowChange": 0.06000042, "fiftyTwoWeekLowChangePercent": 0.006928455, "fiftyTwoWeekRange": "8.66 - 29.6", "fiftyTwoWeekHighChange": -20.880001, "fiftyTwoWeekHighChangePercent": -0.7054054, "fiftyTwoWeekChangePercent": -50.454544, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.51, "epsForward": -2.02, "epsCurrentYear": -2.10883, "priceEpsCurrentYear": -4.1349945, "longName": "Tyra Biosciences, Inc.", "regularMarketChangePercent": -6.236558, "regularMarketPrice": 8.72, "trailingPegRatio": null}